You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PRT 201

Showing 1 - 25 of 372
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Disease Trial in United States (PRT-201, Placebo)

Completed
Has Results
  • Chronic Kidney Disease
  • PRT-201
  • Placebo
  • Birmingham, Alabama
  • +34 more
Jun 17, 2019

Chronic Kidney Disease Trial in Canada, United States (Vonapanitase, Placebo)

Completed
Has Results
  • Chronic Kidney Disease
  • Birmingham, Alabama
  • +40 more
Jul 20, 2019

Peripheral Artery Disease Trial in Charlottesville (vonapanitase)

Withdrawn
  • Peripheral Artery Disease
  • Charlottesville, Virginia
    University of Virginia Health System
Apr 30, 2019

Pain, Chronic, Back Pain Trial in Aurora (Pain reprocessing therapy (PRT), Cognitive Behavioral Therapy for Chronic Pain

Recruiting
  • Pain, Chronic
  • Back Pain
  • Pain reprocessing therapy (PRT)
  • +2 more
  • Aurora, Colorado
    University of Colorado Anschutz Medical Campus
Apr 18, 2023

Peripheral Artery Disease Trial in United States (vonapanitase, Placebo)

Completed
  • Peripheral Artery Disease
  • Long Beach, California
  • +8 more
Apr 30, 2019

Autism Spectrum Disorder, Autism Trial in Stanford (Pivotal Response Treatment Program (PRT-P))

Recruiting
  • Autism Spectrum Disorder
  • Autism
  • Pivotal Response Treatment Program (PRT-P)
  • Stanford, California
    Stanford University
Dec 16, 2022

Autism Spectrum Disorder Trial in Stanford (Pivotal Response Treatment)

Recruiting
  • Autism Spectrum Disorder
  • Pivotal Response Treatment
  • Stanford, California
    Department of Psychiatry and Behavioral Sciences
Oct 13, 2022

Hip Dysplasia Trial in Århus N, Oslo (PAO, Usual care after PAO, PRT)

Recruiting
  • Hip Dysplasia
  • PAO
  • +2 more
  • Århus N, Midtjylland, Denmark
  • +1 more
Aug 1, 2022

Cervical Cancer, Uterine Cancer Trial (Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT))

Not yet recruiting
  • Cervical Cancer
  • Uterine Cancer
  • Whole Pelvis (WP) Pencil Beam Scanning Proton Radiation (PBS PRT)
  • (no location specified)
Feb 24, 2023

Autism Spectrum Disorder Trial in New Haven (Oxytocin, Pivotal Response Treatment, Placebo)

Terminated
Has Results
  • Autism Spectrum Disorder
  • New Haven, Connecticut
    Yale School of Medicine
Aug 8, 2022

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Growth Hormone Deficiency Trial (LUM-201)

Not yet recruiting
  • Growth Hormone Deficiency
  • (no location specified)
Apr 5, 2023

Autism, Autism Spectrum Disorder High-Functioning, Developmental Disability Trial in Palo Alto (PRT for Adolescents)

Not yet recruiting
  • Autism
  • +5 more
  • PRT for Adolescents
  • Palo Alto, California
    Stanford Research Park
Aug 3, 2023

Autism Spectrum Disorder With Impaired Functional Language Trial in Halifax (PRIMeR, PRT)

Recruiting
  • Autism Spectrum Disorder With Impaired Functional Language
  • PRIMeR
  • PRT
  • Halifax, Nova Scotia, Canada
    IWK Health Centre
Aug 19, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Portland, Suwon (AB-201, Cyclophosphamide,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Portland, Oregon
  • +1 more
Jan 12, 2023

Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome Trial in Orange (CAB-201 following preconditioning

Recruiting
  • Idiopathic Inflammatory Myopathy
  • +3 more
  • CAB-201 following preconditioning with fludarabine and cyclophosphamide
  • Orange, California
    University of California Irvine
Nov 30, 2023

Systemic Lupus Erythematosus, Lupus Nephritis Trial in Boston (CABA-201)

Recruiting
  • Systemic Lupus Erythematosus
  • Lupus Nephritis
  • CABA-201
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 7, 2023

Growth Hormone Deficiency Trial in Worldwide (LUM-201, rhGH Norditropin® pen (34 µg/kg))

Recruiting
  • Growth Hormone Deficiency
  • LUM-201
  • rhGH Norditropin® pen (34 µg/kg)
  • Birmingham, Alabama
  • +52 more
Jan 30, 2023

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Uveal Melanoma, Metastatic Trial in Tampa (4.7 microCi 225Ac-MTI-201, 9.5 microCi of 225Ac-MTI-201, 19 microCi of 225Ac-MTI-201)

Recruiting
  • Uveal Melanoma
  • Metastatic
  • 4.7 microCi 225Ac-MTI-201
  • +11 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Aug 9, 2022

Advanced Ovarian Cancer Trial in Seattle (AST-201, Paclitaxel, Carboplatin)

Not yet recruiting
  • Advanced Ovarian Cancer
  • AST-201
  • +4 more
  • Seattle, Washington
    University of Washington
Mar 20, 2023

Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury

Not yet recruiting
  • Moderate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve Injury
  • IncobotulinumtoxinA
  • Placebo
  • (no location specified)
Oct 13, 2023

Light Chain (AL) Amyloidosis Trial in Sacramento (NXC-201 CAR-T)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • NXC-201 CAR-T
  • Sacramento, California
    University of California Davis Medical Center
Oct 19, 2023

Allergic Conjunctivitis Trial in Andover (PRT-2761 0.5%, PRT-2761 1%, Patanol)

Completed
Has Results
  • Allergic Conjunctivitis
  • PRT-2761 0.5%
  • +4 more
  • Andover, Massachusetts
    Andover Eye Associates
Oct 13, 2022

Chronic Low-back Pain, Degenerative Disc Disease Trial in Miami (CELZ-201-DDT, Placebo)

Not yet recruiting
  • Chronic Low-back Pain
  • Degenerative Disc Disease
  • Miami, Florida
    University of Miami
Sep 25, 2023